DUCRESSA gtt opht fl 5 ml
7680681650010
CH-68165
S01CA01
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Ducressa 1 mg / mL & 5 mg / mL, collyre en solution
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
levofloxacinum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
levofloxacinum hemihydricum
|
- | Substance | WIZUS |
|
dexamethasonum
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
dexamethasoni natrii phosphas
|
- | Substance | WIZUS |
|
benzalkonii chloridi solutio
|
0.1 MG | Substance | HBESI |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
dinatrii phosphas dodecahydricus
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum dilutum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
phosphas
|
4.01 MG | Substance | HBESI |
Authorization holder
Santen SA
1202 Genève
Authorization information
- Swissmedic authorization number
- 68165
- Drug name
- Ducressa, collyre en solution
- Galenic form
- AUL
- ATC Code
- S01CA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/03/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 11.06.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DUCRESSA gtt opht fl 5 ml
- Description (DE)
- DUCRESSA Gtt Opht Fl 5 ml
- Market launch
- 26/03/2021
- Narcotic (BTM)
- No